Cargando…
Meta-Analysis of Serum Gastrin-Releasing Peptide Precursor as a Biomarker for Diagnosis of Small Cell Lung Cancer
BACKGROUND: The serum level of gastrin-releasing peptide precursor (proGRP) is generally? elevated in patients with small cell lung cancer (SCLC). However, the diagnostic sensitivity and specificity of serum proGRP in SCLC cases remains controversial. The study aimed to assess the diagnostic value o...
Autores principales: | Lv, Shui ping, Wang, Yi, Huang, Lang, Wang, Fei, Zhou, Jian guo, Ma, Hu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454733/ https://www.ncbi.nlm.nih.gov/pubmed/28345820 http://dx.doi.org/10.22034/APJCP.2017.18.2.391 |
Ejemplares similares
-
Serum Cystatin, Chemokine, and Gastrin-Releasing Peptide Precursors and Their Clinical Value in Patients with Chronic Renal Failure
por: Liu, Xiaoli, et al.
Publicado: (2022) -
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023) -
Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
por: Wojcik, Ewa, et al.
Publicado: (2017) -
Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer
por: Wang, Jin-Ping, et al.
Publicado: (2019) -
Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis
por: Pendharkar, Sayali A., et al.
Publicado: (2017)